Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show

BioUtah and the University of Utah's Center for Technology & Venture Commercialization Announce Early Bird Registration for the 2020 Entrepreneur and Investor Summit


BioUtah, Utah's only trade association dedicated solely to the life sciences, in partnership with the University of Utah's Center for Technology & Venture Commercialization (TVC), today announced that early bird registration is open for the 2020 Entrepreneur and Investor (E&I) Summit. The E&I Summit connects Utah life sciences entrepreneurs, as well as early and late-stage companies that are on the frontline of health innovation, with local and nationally recognized investors.

The conference will be held on February 28, 2020 at the University of Utah's Cleone Peterson Eccles Alumni House and proudly sponsored by Simpson Thacher. Early bird discounts are available for both members and non-members who register by January 31. For sponsor and exhibitor information view the Sponsor and Exhibitor Prospectus.

The E&I Summit will host a notable group of speakers and panelists, including industry leaders, mentors, entrepreneurs, investors, economic analysts, and investment experts. The program will also provide opportunities for companies to engage directly with investors.

"We're designing the agenda to put innovators directly in touch with key investors who can discuss financing options, and industry leaders who can share valuable lessons learned," said Kelvyn Cullimore, president and CEO of BioUtah. "Whether you're looking for partners, funding, networking or expert advice, this is the place to be."

"The sessions will reflect the needs and diversity of Utah's life sciences industry," said Keith Marmer, executive director and associate vice president of the TVC. "Our goal is to help move the dial in terms of access to investor capital and fostering an environment where new medical technologies and treatments can take root and succeed."

About BioUtah

BioUtah is an independent 501(c)(6) trade association serving Utah's life sciences industry. Its member companies reflect a broad spectrum of the industry with strengths in medical device manufacturing and services, research and testing, biotechnology, biopharmaceuticals, and advanced diagnostics, amongst others; and are a key driver of Utah's economy.

About the Center for Technology & Venture Commercialization

The Center for Technology & Venture Commercialization is dedicated to helping the University of Utah's faculty inventors bring their innovations to market. TVC is responsible for all aspects of invention management, patent prosecution, licensing, startup formation and support, equity management and early-stage funding. The center's mission is to expand the university's reputation for innovation, and positively impact society. TVC is proud to help foster this spirit of discovery.


These press releases may also interest you

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....



News published on and distributed by: